Clostridium Vaccine (Animal Health) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Clostridium Vaccine (Animal Health) Market -
Global Industry Analysis, Size, Share, Growth,
Trends and Forecast 2016 - 2024
Global Clostridium Vaccines Market: Snapshot
Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial
diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and
tetanus. The demand for clostridium vaccine is rising globally owing to the
increasing incidence rate of clostridium family diseases and increased awareness
regarding zoonotic diseases. Rising concerns about the mortality of livestock animal
and the socioeconomic impact of it on agrarian economies are also increasing the
demand for clostridium vaccines in developing countries globally.
Clostridium vaccine is are chiefly distributed through veterinary clinics and
veterinary hospitals. In developing countries such as India, the distribution of these
vaccines is highly dependent on government intervention. However, there has been
a significant rise in the demand for these vaccines through retail pharmacies, which
allow instant access to these vaccines without having to wait for government
channels to distribute them.
The global clostridium vaccine (animal health) market is poised to observe
significant growth in the future. Transparency Market Research estimates that the
market was valued at US$418.0 mn in 2015 and is expected to reach US$643.5 mn
by 2024, expanding at a CAGR of 4.9% from 2016 to 2024.
View Report @ http://www.transparencymarketresearch.com/clostridiumvaccine-market.html
Bovine Segment to Bring in Significant Percentage of Sales
On the basis of animal species, the global clostridium vaccine market is segmented
into bovine, ovine, caprine, swine, and poultry. Of these, the swine segment
emerged as the most attractive segment of the market in 2015. The large share of
the segment in the global market's overall revenues can be attributed to the large
demand of pork and high awareness about the possibility of swines causing zoonotic
diseases.
Over the forecast period, however, the ovine segment is likely to record the most
promising growth rate. The rising prevalence of diseases such as blackleg, black
diseases, and black quarter, along with the vast rise in the world's ovine population,
growing awareness among owners, and government regulations in different

geographies will be key to the increased demand for clostridium vaccines across
this segment. In addition, the increase in demand for immunization has led to the
growth of this segment. Poultry is also expected grow with high growth rate due to
increase consumption of poultry goods.
Get accurate market forecast and analysis on the Clostridium Vaccine
market. Request a sample to stay abreast on the key trends impacting this
market.
http://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=16682
Rising Awareness Regarding Animal Health to Boost Demand across Asia
Pacific
Geographically, North America was the leading market for the clostridium vaccine
market in 2015. The region accounted for a share of 37.6% of the market and is
expected to continue to constitute the bulk of the global market’s revenue over the
forecast period as well. Rising demand for effective veterinary healthcare services
and substantial government interventions for research and development are the key
factors supporting the North America market’s growth.
The swine segment in North America accounted for the dominant share of 25.3%
share in 2015. A wide range of applications, including clostridium perfringens and
clostridium botulinum are likely to support the growth of the segment in the next
few years.
Nevertheless, the clostridium vaccine market in Asia Pacific is anticipated to
outpace the rate of growth of the North America market over the forecast period
owing to a vast rise in prevalence of clostridium disease infections in developing
countries such as India and China. India and New Zealand are expected to be more
lucrative than other countries in Asia Pacific due to increased awareness as well as
increasing livestock animal population in these countries. Veterinary clinic as
distribution channel holds the dominant market share due to increasing government
awareness regarding the diseases across several countries in the region.
The global clostridium vaccine (animal health) market features a largely
consolidated competitive landscape, with a relatively small number of companies
accounting for a majority of share in the global market. Some of the key players in
the market Zoetis, Inc., Merck Animal Health, Sanofi-Aventis (Merial Animal Health),
BoehringerIngelheim, Eli Lilly and Company (Elanco Animal Healthcare), Vibrac
Corporation, Bimeda, Inc., CevaSanteAnimale, and Bayer AG.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of decision makers. TMR’s

experienced team of analysts, researchers, and consultants, use proprietary data sources and
various tools and techniques to gather, and analyze information. Our business offerings represent
the latest and the most reliable information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and
technology. These reports provide in-depth analysis and deep segmentation to possible micro
levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to
provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com